|Bid||69.68 x 800|
|Ask||70.01 x 1100|
|Day's Range||69.59 - 70.45|
|52 Week Range||64.62 - 104.83|
|Beta (5Y Monthly)||0.61|
|PE Ratio (TTM)||31.88|
|Earnings Date||Oct 31, 2023 - Nov 06, 2023|
|Forward Dividend & Yield||2.42 (3.47%)|
|Ex-Dividend Date||Oct 19, 2023|
|1y Target Est||90.54|
Subscribe to Yahoo Finance Plus to view Fair Value for CVS
Aetna®, a CVS Health® company (NYSE: CVS), announces our 2024 Medicare products ― the largest Medicare offering in our history1 ― featuring more choices, flexible benefit allowances, a strong provider network and further simplified medical and prescription drug plans that support members' overall health and well-being. We included dental, vision and hearing benefits on every Medicare Advantage (MA) plan, reduced prescription drug costs across our Medicare Advantage Prescription Drug (MAPD) plan
Investors looking for smart ways to bump up their stream of passive income want to push their shopping carts toward the healthcare aisle. Here's how they could pump up your recurring stream of passive income. Earlier this year, Johnson & Johnson spun its consumer health segment off into a new company called Kenvue.
Burry has taken highly publicized short positions on Tesla stock. Here's the Michael Burry stock that could be the biggest winner over the next five years, in my opinion. You can easily find every stock that Burry's Scion Asset Management owns by looking at the private investment firm's 13-F filings to the U.S. Securities and Exchange Commission.